{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:00:36Z","timestamp":1783472436645,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.01.054","type":"journal-article","created":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T13:15:34Z","timestamp":1360242934000},"page":"1819-1829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010"],"prefix":"10.1016","volume":"31","author":[{"given":"J.G.","family":"Breugelmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.F.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Agbenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Veit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"B\u00f6the","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Perea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Niedrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yactayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.01.054_bib0005","unstructured":"World Health Organization Yellow Fever Initiative \u2013 Providing an opportunity of a lifetime. 2010. WHO\/HSE\/GAR\/ERI\/2010.3 http:\/\/www.who.int\/csr\/disease\/yellowfev\/brochure\/en\/index.html [accessed 6.01.13]."},{"issue":"9276","key":"10.1016\/j.vaccine.2013.01.054_bib0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"issue":"9276","key":"10.1016\/j.vaccine.2013.01.054_bib0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"issue":"9276","key":"10.1016\/j.vaccine.2013.01.054_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.01.054_bib0025","unstructured":"Centers for Disease Control and Prevention Adverse events associated with 17D-derived yellow fever vaccination\u2013United States, 2001\u20132002. MMWR Morb Mortal Wkly Rep 2002 November 8;51(44):989\u201393."},{"issue":"50","key":"10.1016\/j.vaccine.2013.01.054_bib0030","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.054_bib0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2006.02.005","article-title":"Yellow fever vaccine-associated viscerotropic disease and death in Spain","volume":"36","author":"Doblas","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2013.01.054_bib0040","unstructured":"Centers for Disease Control and Prevention Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010 July 30;59(RR-7):1\u201327."},{"issue":"10","key":"10.1016\/j.vaccine.2013.01.054_bib0045","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","article-title":"Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases","volume":"25","author":"McMahon","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.054_bib0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/14740330902808086","article-title":"Safety of 17D derived yellow fever vaccines","volume":"8","author":"Domingo","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"25","key":"10.1016\/j.vaccine.2013.01.054_bib0055","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2013.01.054_bib0060","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","author":"Lindsey","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.054_bib0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.provac.2010.07.012","article-title":"Yellow fever vaccine post-marketing surveillance in Brazil","volume":"2","author":"Martins","year":"2010","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.vaccine.2013.01.054_bib0070","unstructured":"World Health Organization Surveillance of adverse events following immunization against yellow fever: field guide for staff at the central, intermediate and peripheral level, 2010. 2010. Available on the world wide web: http:\/\/whqlibdoc.who.int\/hq\/2010\/WHO_HSE_GAR_ERI_2010.1_eng.pdf [last accessed 6.01.13]."},{"key":"10.1016\/j.vaccine.2013.01.054_bib0075","unstructured":"ICH Harmonised Tripartite guidelines. Clinical safety data management: definitions and standards for expedited reporting E2A. 1994. Available on the world wide web: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E2A\/Step4\/E2A_Guideline.pdf [last accessed 6.01.13]."},{"key":"10.1016\/j.vaccine.2013.01.054_bib0080","unstructured":"World Health Organization Immunization safety surveillance: guidelines for managers of immunization programmes on reporting and investigating adverse events following immunization. 1999. Available on the world wide web: http:\/\/www.who.int\/immunization_safety\/publications\/aefi\/en\/AEFI_WPRO.pdf [last accessed 6.01.13]."},{"key":"10.1016\/j.vaccine.2013.01.054_bib0085","unstructured":"World Health Organization Detection and investigation of serious adverse events following yellow fever vaccination: guidance from an informal consultation of experts, 18\u201319 November 2008, Geneva, Switzerland, 2010. Available on the world wide web: http:\/\/whqlibdoc.who.int\/hq\/2010\/WHO_HSE_GAR_ERI_2010.2_eng.pdf [last accessed 6.01.13]."},{"key":"10.1016\/j.vaccine.2013.01.054_bib0090","unstructured":"Centers for Disease Control and Prevention and the Food and Drug Administration Vaccine Adverse Event Reporting System (VAERS). http:\/\/vaers.hhs.gov\/index [last accessed 6.01.2013]."},{"issue":"31","key":"10.1016\/j.vaccine.2013.01.054_bib0095","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2013.01.054_bib0100","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1016\/j.vaccine.2007.04.058","article-title":"Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data","volume":"25","author":"Tapiainen","year":"2007","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2013.01.054_bib0105","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2007.04.060","article-title":"Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Sejvar","year":"2007","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2013.01.054_bib0110","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1016\/j.vaccine.2012.04.067","article-title":"Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"30","author":"Gershman","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2013.01.054_bib0115","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1128\/JCM.01799-12","article-title":"Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories","volume":"50","author":"Domingo","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.054_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-0934(03)00129-0","article-title":"Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay","volume":"110","author":"Bae","year":"2003","journal-title":"J Virol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.054_bib0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2013.01.054_bib0130","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop Med Int Health"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.054_bib0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/CVI.00078-07","article-title":"Evaluation of an indirect immunofluorescence assay for detection of immunoglobulin M (IgM) and IgG antibodies against yellow fever virus","volume":"15","author":"Niedrig","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2013.01.054_bib0140","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1086\/587844","article-title":"Immune response during adverse events after 17D-derived yellow fever vaccination in Europe","volume":"197","author":"Bae","year":"2008","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2013.01.054_bib0145","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/JCM.39.5.1922-1927.2001","article-title":"Comparison of flavivirus universal primer pairs and development of a rapid, highly sensitive heminested reverse transcription-PCR assay for detection of flaviviruses targeted to a conserved region of the NS5 gene sequences","volume":"39","author":"Scaramozzino","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.01.054_bib0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0166-0934(97)00035-9","article-title":"Detection of enteroviral RNA and specific DNA of herpesviruses by multiplex genome amplification","volume":"66","author":"Casas","year":"1997","journal-title":"J Virol Methods"},{"issue":"9","key":"10.1016\/j.vaccine.2013.01.054_bib0155","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1128\/JCM.00317-10","article-title":"Detection of all species of the genus Alphavirus by reverse transcription-PCR with diagnostic sensitivity","volume":"48","author":"Grywna","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2013.01.054_bib0160","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/jcm.32.12.2898-2903.1994","article-title":"Early diagnosis of Lassa fever by reverse transcription-PCR","volume":"32","author":"Demby","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2013.01.054_bib0165","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2004.01.026","article-title":"Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX","volume":"22","author":"Kitchener","year":"2004","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.01.054_bib0170","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4269\/ajtmh.2009.09-0295","article-title":"Short report: incidence of yellow fever vaccine-associated neurotropic disease","volume":"81","author":"Guimard","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.054_bib0175","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.vaccine.2004.05.018","article-title":"Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast","volume":"23","author":"Fitzner","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.01.054_bib0180","series-title":"Vaccines","first-page":"959","article-title":"Yellow fever vaccine","author":"Monath","year":"2008"},{"key":"10.1016\/j.vaccine.2013.01.054_bib0185","unstructured":"World Health Organization Yellow fever vaccine. WHO posiiton paper. Weekly Epidemiological Record 2003; 40 (78) 349\u2013360."},{"key":"10.1016\/j.vaccine.2013.01.054_bib0190","unstructured":"Central Intelligence Agency The World Factbook. Available on the world wide web: https:\/\/www.cia.gov\/library\/publications\/the-world-factbook [last accessed 6.01.13]."},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.01.054_bib0195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.aje.a121232","article-title":"Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans","volume":"93","author":"Monath","year":"1971","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.054_bib0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-004-0003-3","article-title":"Interactions between worm infections and malaria","volume":"26","author":"Nacher","year":"2004","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.vaccine.2013.01.054_bib0205","unstructured":"World Health Organization WHO Programme for International Drug Monitoring. Available on the world wide web: http:\/\/www.who.int\/medicines\/areas\/quality_safety\/safety_efficacy\/National_PV_Centres_Map\/en\/index.html [last accessed 6.01.13]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:19:10Z","timestamp":1759400350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13001321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":41,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0264410X13001321"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.01.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.01.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}